Table 1 Patient characteristics
CKD stage 3 (n = 1039) | CKD stage 4 (n = 834) | Dialysis (n = 1025) | Total (n = 2898) | |
|---|---|---|---|---|
Sex, n (%) | ||||
Female | 411 (40) | 343 (41) | 410 (40) | 1164 (40) |
Male | 628 (60) | 491 (59) | 615 (60) | 1734 (60) |
Age, years | ||||
Mean ± SD | 63.4 ± 14.7 | 66.9 ± 14.5 | 61.5 ± 15.4 | 63.7 ± 15.1 |
≥65, n (%) | 548 (53) | 535 (64) | 490 (48) | 1573 (54) |
Body mass index, kg/m2 | ||||
Mean ± SD | 26.8 ± 4.7 | 27.0 ± 5.3 | 25.7 ± 4.9 | 26.5 ± 5.0 |
≥30, n (%) | 210 (20) | 178 (21) | 155 (15) | 543 (19) |
˂ 30, n (%) | 792 (76) | 624 (75) | 822 (80) | 2238 (77) |
Missing | 37 (4) | 32 (4) | 48 (5) | 117 (4) |
Anaemia status, n (%) | ||||
Anaemic | 453 (44) | 633 (76) | 887 (87) | 1973 (68) |
Non-anaemic | 479 (46) | 177 (21) | 84 (8) | 740 (26) |
Missing | 107 (10) | 24 (3) | 54 (5) | 185 (6) |
ESA and/or iron use, n (%) | 197 (19) | 420 (50) | 801 (78) | 1418 (49) |
Country, n (%) | ||||
France | 206 (20) | 177 (21) | 190 (19) | 573 (20) |
Germany | 238 (23) | 168 (20) | 306 (30) | 712 (25) |
Italy | 214 (21) | 161 (19) | 190 (19) | 565 (20) |
Spain | 232 (22) | 182 (22) | 190 (19) | 604 (21) |
UK | 149 (14) | 146 (18) | 149 (15) | 149 (15) |
Comorbidities, n (%) | ||||
Hypertension | 903 (87) | 741 (89) | 725 (71) | 2369 (82) |
SHPT | 256 (25) | 476 (57) | 688 (67) | 1420 (49) |
Type 2 diabetes | 457 (44) | 355 (43) | 335 (33) | 1147 (40) |
Dyslipidaemia | 448 (43) | 365 (44) | 335 (33) | 1148 (40) |
Employment status, n (%) | ||||
Employed a | 288 (28) | 142 (17) | 199 (19) | 629 (22) |
Retired | 535 (51) | 511 (61) | 539 (53) | 1585 (55) |
Other b | 216 (21) | 181 (22) | 287 (28) | 684 (24) |